Morgan Stanley in its note said that they expect the stock’s relative underperformance to continue as revenue growth lags behind peers, with limited visibility of any near-term improvement.
Morgan Stanley in its note said that they expect the stock’s relative underperformance to continue as revenue growth lags behind peers, with limited visibility of any near-term improvement.